<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Public Health">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Public Health</JournalTitle>
      <Issn>2251-6085</Issn>
      <Volume>54</Volume>
      <Issue>12</Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>12</Month>
        <Day>31</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Specific Genes and microRNAs as Novel Diagnostic Biomarkers for the Potential Progression of Pulmonary Arterial Hypertension</title>
    <FirstPage>2754</FirstPage>
    <LastPage>2763</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Akram</FirstName>
        <LastName>Gholipour</LastName>
        <affiliation locale="en_US">Cardiogenetic Research Center, Rajaie Cardiovascular Institute, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Molood</FirstName>
        <LastName>Farsi</LastName>
        <affiliation locale="en_US">Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Faezeh</FirstName>
        <LastName>Sari</LastName>
        <affiliation locale="en_US">Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Khajali</LastName>
        <affiliation locale="en_US">1.	Cardiogenetic Research Center, Rajaie Cardiovascular Institute, Tehran, Iran 2.	Congenital Heart Diseases Research Center, Rajaie Cardiovascular Institute, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Majid</FirstName>
        <LastName>Maleki</LastName>
        <affiliation locale="en_US">Cardiogenetic Research Center, Rajaie Cardiovascular Institute, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mahshid</FirstName>
        <LastName>Malakootian</LastName>
        <affiliation locale="en_US">1.	Cardiogenetic Research Center, Rajaie Cardiovascular Institute, Tehran, Iran 2.	Vascular Disease and Thrombosis Research Center, Rajaie Cardiovascular Institute, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>05</Month>
        <Day>02</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>10</Month>
        <Day>19</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Pulmonary arterial hypertension (PAH) is characterized by high blood pressure in the lungs due to obstruction of small pulmonary arteries. Its exact cause is unknown. We aimed to identify specific genes, signaling pathways, and microRNAs (miRNAs) as novel diagnostic biomarkers for PAH progression.
Methods: We analyzed differentially expressed genes (DEGs) from PAH and control samples in the GSE144932 and GSE131793 datasets using GEO2R. We performed GO enrichment and KEGG pathway analyses. miRNAs targeting common DEGs were identified using miRDB and TargetScan.
Results: MYLK and CLU were upregulated in both datasets, implicating calcium signaling and coagulation pathways, respectively. In silico analysis showed that miR-9-5p, miR-3179, and miR-580-3p potentially target MYLK; miR-369-3p potentially targets CLU; and miR-499a-5p potentially targets both.
Conclusion: This study identifies MYLK and CLU, and their associated miRNAs (miR-9-5p, miR-3179, miR-580-3p, miR-499a-5p, and miR-369-3p), as potential noninvasive diagnostic biomarkers for PAH, requiring experimental validation.&#xA0;</abstract>
    <web_url>https://ijph.tums.ac.ir/index.php/ijph/article/view/38971</web_url>
    <pdf_url>https://ijph.tums.ac.ir/index.php/ijph/article/download/38971/8735</pdf_url>
  </Article>
</Articles>
